Additionally, while high levels of GH and GHR expression are associated with poorer prognosis in several cancer types [15,16,17,18], this relationship is not consistent across all cancers—for example, it is not observed in liver cancer or renal clear cell carcinoma [19]. The gene discussed is GH1; the disease is cancer.